Tobrex Related Clinical Trials
Tobramycin Inhalation Solution Administered by eFlow Rapid Nebulizer: Scintigraphy Study [Completed]
Tobramycin Administered by eFlow Rapid Nebulizer: Pharmacokinetic Study [Completed]
The Tobramycin Study [Completed]
Efficacy and Safety of 28 or 56 Days Treatment With Inhaled Tobramycin Nebuliser Solution for Pseudomonas Aeruginosa Infection in Children With Cystic Fibrosis. [Active, not recruiting]
Safety of Tobramycin Inhalation Powder (TIP) vs Tobramycin Solution for Inhalation in Patients With Cystic Fibrosis [Recruiting]
Tobramycin Inhalation Powder (TIP) in Cystic Fibrosis Subjects [Terminated]
Aztreonam for Inhalation Solution (AZLI) vs Tobramycin Inhalation Solution (TOBI®) in Patients With CF & P. Aeruginosa [Recruiting]
Pharmacokinetic Evaluation of an 8 -Week Treatment With Inhaled Tobramycin [Recruiting]
A Study Comparing the Efficacy and Tolerability of Tobrineb®/Actitob®/Bramitob® Versus TOBI® [Not yet recruiting]
Tobramycin Tear Concentrations [Not yet recruiting]
A Study of Tobramycin Inhalation Powder From a Modified Manufacturing Process Versus Placebo [Recruiting]
Comparison of Two Treatment Regimens to Reduce PA Infection in Children With Cystic Fibrosis [Active, not recruiting]
Safety and Efficacy of Zylet vs Lotemax, Tobramycin and Vehicle in Pediatric Blepharoconjunctivitis [Recruiting]
A Study of the Safety and Efficacy of Tobramycin for Inhalation in Young Children With Cystic Fibrosis [Completed]
A Bioequivalence Study of Tobramycin and Prednisolone Acetate Compared to PredForte [Completed]
Zylet vs TobraDex in Blepharokeratoconjunctivitis [Completed]
Study Evaluating Fosfomycin/Tobramycin for Inhalation in Cystic Fibrosis Patients With Pseudomonas Aeruginosa Lung Infection [Recruiting]
Nasal Inhalation of Tobramycin in Patients With Cystic Fibrosis and Pseudomonas Aeruginosa Colonization [Recruiting]
Phase III Randomized Study of the Inhalation of Tobramycin in Patients With Cystic Fibrosis [Completed]
Evaluation of Clinical and Microbial Efficacy and Safety of AzaSite Compared to Tobramycin for Bacterial Conjunctivitis [Completed]
Tobradex BID Compared to TOBRADEX and TOBREX/Vehicle [Withdrawn]
Amiloride Solution and Tobramycin Solution for Inhalation for the Eradication of Burkholderia Dolosa in Patients With Cystic Fibrosis [Active, not recruiting]
Pediatric Zylet Safety and Efficacy Study [Recruiting]
Ocular Tolerance and Intraocular Pressure (IOP) Effects of Zylet Versus Tobradex [Completed]
Efficacy and Safety of T1225 1.5% Versus Tobramycin 0.3 % in the Treatment of Purulent Bacterial Conjunctivitis [Completed]
TOBRADEX Ophthalmic Suspension Versus Tobramycin 0.3%/Dexamethasone 0.05% Ophthalmic Suspension [Completed]
Standard vs. Biofilm Susceptibility Testing in Cystic Fibrosis (CF) [Completed]
Antimicrobial Resistance in Cystic Fibrosis (CF) [Recruiting]
Ventilator-Associated Pneumonia/Hospital-Acquired Pneumonia Requiring Mechanical Ventilatory Support [Completed]
Evaluating SPRC-AB01 in Post-Surgical Subjects With Chronic Sinusitis [Completed]
Continuous Versus Short Infusions of Ceftazidime in Cystic Fibrosis [Terminated]
"Safety, Tolerability and Pharmacokinetics of MP-376 Administered for 14 Days to Stable Pediatric (CF) Patients" [Not yet recruiting]
Topical Antibiotic Use In Chronic Rhinosinusitis A Double-Blinded, Randomized, Placebo Controlled Study [Recruiting]
Premium Migraine Trial [Recruiting]
Safety and Efficacy Study of ICXP007 With Compression Bandaging for the Treatment of Non-Infected Venous Leg Ulcers [Recruiting]
Negative Pressure Wound Therapy for the Treatment of Chronic Pressure Wounds [Recruiting]
|
